Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Rheumatology and Bone Research (CRBR) is a premier clinical research site and a division of Arthritis and Rheumatism Associates, P.C. (ARA). Based in the Washington, D.C. metropolitan area, the center specializes in conducting Phase I through IV clinical trials for a wide range of rheumatic and inflammatory diseases. CRBR partners with major pharmaceutical and biotechnology companies to evaluate the safety and efficacy of emerging therapies for conditions such as rheumatoid arthritis, lupus, and osteoporosis. With over 30 years of experience, the center has participated in hundreds of trials that have contributed to the FDA approval of numerous breakthrough treatments. The facility is staffed by board-certified rheumatologists and experienced research coordinators dedicated to advancing musculoskeletal medicine. CRBR is recognized for its high-quality data collection and commitment to patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Rheumatology and Bone Research.